about
Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial FibrillationComparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial FibrillationPilot Randomized Trial With Flecainide in ARVC PatientsINhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)Kansai Plus Atrial Fibrillation TrialCardiac Arrhythmia Suppression Trial (CAST)Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract
P4844
Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean mImpact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life.Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate.Flecainide acetate for the treatment of atrial and ventricular arrhythmias.Antiarrhythmic and hemodynamic actions of flecainide acetate (R-818) in the ischemic porcine heart.A case of acute ventricular capture threshold rise associated with flecainide acetateAcute loss of capture due to flecainide acetate.Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.Skin biopsy-proven flecainide-induced neuropathyStability of flecainide acetate in an extemporaneously compounded oral suspensionElectrophysiologic effects of flecainide acetate in patients with sinus nodal dysfunctionRelationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patientsMeasurement of flecainide acetate in human plasma by an extraction spectrophotofluorometric methodConjugated hyperbilirubinemia in a newborn infant after maternal (transplacental) treatment with flecainide acetate for fetal tachycardia and fetal hydropsSuccessful treatment of supraventricular tachycardia with flecainide acetate: a case reportFlecainide acetate acetic acid solvates
P921
Q61862265-4CFEC0A2-6D49-48EE-B3A9-4F283FBF8975Q61909130-6EC95C62-D9E9-4AA5-B82A-C7CCE8F5E85AQ62054596-607887CB-4704-4728-AD95-BA9FDBD3BA55Q62812728-DCD19A7A-5C7D-41E1-8792-15E0B39453EFQ63320354-9F470DC6-25D8-4115-88E9-866BE4AB0D97Q63581384-D9EF5FD8-2DCD-48AF-A205-4200E4B43764Q63600406-C8210BE3-D373-4231-B404-4D19CC3F5A1F
P4844
Q33569741-773D5477-7040-4AEE-9ABC-9047E11AA972Q33811334-35A153D4-AA05-43C7-948A-86F379DD863DQ34131782-92CEFFCA-7A62-4F8A-A69E-A5E4F13F122DQ38072091-E09F2845-1C3C-4E43-AFA3-9AD53C299531Q39591676-F630F9C9-3456-49BB-9DC1-0214108C64D2Q41841014-A5F7280F-4366-4B46-8B6F-04A086A9AD13Q43689578-18AF0175-A59E-45DE-9262-3D1B00C5C449Q54502327-B2807239-E4C9-4D16-BCE8-0075C49748D3Q58135429-71172494-CF13-49CE-BE10-CBF0A2B03947Q68051136-18D890CA-451A-4B3B-8C23-BC29F1FEB839Q70501528-0EEBD8AD-6C02-4A35-B84D-E873AC389C16Q70674826-975DF00C-EDAD-4208-9570-941B3F4C500FQ71230640-ACF4BD8C-E900-4473-8141-E310AFE38FFBQ72300248-44E6F933-4894-4130-B0E5-10819417246AQ74220445-1FEBA6C4-50A8-471A-93E5-5B108B73B71CQ83243133-E550749F-5C43-400E-BC4C-F31BF9E9A58D
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
flecainide acetate
@en
type
label
flecainide acetate
@en
altLabel
N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate
@en
R 818
@en
R-818
@en
almarytm
@it
flecainide monoacetate
@en
prefLabel
flecainide acetate
@en
P592
P661
P662
P683
P1579
P2067
474.158941
P2115
N0000147125
P231
54143-56-5
P232
P233
CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F
P234
1S/C17H20F6N2O3.C2H4O2/c18-16( ...... 6,8-10H2,(H,25,26);1H3,(H,3,4)
P235
RKXNZRPQSOPPRN-UHFFFAOYSA-N
P2566
100.053.616
P274
C₁₉H₂₄F₆N₂O₅
P2892
P3117
DTXSID8020626
P3345
P592
CHEMBL1200822
P652
M8U465Q1WQ